AAAAAA

   
Results: 1-10 |
Results: 10
Global methylation profiling of lung cancer identifies novel methylated genes
Authors: Dai, ZY Lakshmanan, RR Zhu, WG Smiraglia, DJ Rush, LJ Fruhwald, MC Brena, RM Li, B Wright, FA Ross, P Otterson, GA Plass, C
Citation: Zy. Dai et al., Global methylation profiling of lung cancer identifies novel methylated genes, NEOPLASIA, 3(4), 2001, pp. 314-323
Aberrant hypermethylation of the major breakpoint cluster region in 17p11.2 in medulloblastomas but not supratentorial PNETs
Authors: Fruhwald, MC O'Dorisio, MS Dai, ZY Rush, LJ Krahe, R Smiraglia, DJ Pietsch, T Elsea, SH Plass, C
Citation: Mc. Fruhwald et al., Aberrant hypermethylation of the major breakpoint cluster region in 17p11.2 in medulloblastomas but not supratentorial PNETs, GENE CHROM, 30(1), 2001, pp. 38-47
Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies
Authors: Smiraglia, DJ Rush, LJ Fruhwald, MC Dai, ZY Held, WA Costello, JF Lang, JC Eng, C Li, B Wright, FA Caligiuri, MA Plass, C
Citation: Dj. Smiraglia et al., Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies, HUM MOL GEN, 10(13), 2001, pp. 1413-1419
Aberrant promoter methylation of previously unidentified target genes is acommon abnormality in medulloblastomas - Implications for tumor biology and potential clinical utility
Authors: Fruhwald, MC O'Dorisio, MS Dai, ZY Tanner, SM Balster, DA Gao, X Wright, FA Plass, C
Citation: Mc. Fruhwald et al., Aberrant promoter methylation of previously unidentified target genes is acommon abnormality in medulloblastomas - Implications for tumor biology and potential clinical utility, ONCOGENE, 20(36), 2001, pp. 5033-5042
Hypermethylation as a potential prognostic factor and a clue to a better understanding of the molecular pathogenesis of medulloblastoma - Results of a genomewide methylation scan
Authors: Fruhwald, MC O'Dorisio, MS Smith, L Dai, Z Wright, FA Paulus, W Jurgens, H Plass, C
Citation: Mc. Fruhwald et al., Hypermethylation as a potential prognostic factor and a clue to a better understanding of the molecular pathogenesis of medulloblastoma - Results of a genomewide methylation scan, KLIN PADIAT, 213(4), 2001, pp. 197-203
Aberrant CpG-island methylation has non-random and tumour-type-specific patterns
Authors: Costello, JF Fruhwald, MC Smiraglia, DJ Rush, LJ Robertson, GP Gao, X Wright, FA Feramisco, JD Peltomaki, P Lang, JC Schuller, DE Yu, L Bloomfield, CD Caligiuri, MA Yates, A Nishikawa, R Huang, HJS Petrelli, NJ Zhang, XL O'Dorisio, MS Held, WA Cavenee, WK Plass, C
Citation: Jf. Costello et al., Aberrant CpG-island methylation has non-random and tumour-type-specific patterns, NAT GENET, 24(2), 2000, pp. 132-138
Gene amplification in PNETs/medulloblastomas: mapping of a novel amplifiedgene within the MYCN amplicon
Authors: Fruhwald, MC O'Dorisio, MS Rush, LJ Reiter, JL Smiraglia, DJ Wenger, G Costello, JF White, PS Krahe, R Brodeur, GM Plass, C
Citation: Mc. Fruhwald et al., Gene amplification in PNETs/medulloblastomas: mapping of a novel amplifiedgene within the MYCN amplicon, J MED GENET, 37(7), 2000, pp. 501-509
A new tool for the rapid cloning of amplified and hypermethylated human DNA sequences from restriction landmark genome scanning gels
Authors: Smiraglia, DJ Fruhwald, MC Costello, JF McCormick, SP Dai, ZY Peltomaki, P O'Dorisio, MS Cavenee, WK Plass, C
Citation: Dj. Smiraglia et al., A new tool for the rapid cloning of amplified and hypermethylated human DNA sequences from restriction landmark genome scanning gels, GENOMICS, 58(3), 1999, pp. 254-262
High expression of somatostatin receptor subtype 2 (sst(2)) in medulloblastoma: Implications for diagnosis and therapy
Authors: Fruhwald, MC O'Dorisio, MS Pietsch, T Reubi, JC
Citation: Mc. Fruhwald et al., High expression of somatostatin receptor subtype 2 (sst(2)) in medulloblastoma: Implications for diagnosis and therapy, PEDIAT RES, 45(5), 1999, pp. 697-708
Vasoactive intestinal peptide (VIP) and VIP receptors: Gene expression andgrowth modulation in medulloblastoma and other central primitive neuroectodermal tumors of childhood
Authors: Fruhwald, MC O'Dorisio, MS Fleitz, J Pietsch, T Reubi, JC
Citation: Mc. Fruhwald et al., Vasoactive intestinal peptide (VIP) and VIP receptors: Gene expression andgrowth modulation in medulloblastoma and other central primitive neuroectodermal tumors of childhood, INT J CANC, 81(2), 1999, pp. 165-173
Risultati: 1-10 |